Translating Infection Reduction's Impact on Length of Stay & Revenue

Why It Matters

Demonstrating the financial return of infection‑prevention equips leaders to allocate resources, improve patient throughput, and protect the bottom line, turning safety initiatives into strategic revenue drivers.

Key Takeaways

• Quantify infection reduction to demonstrate cost savings and LOS improvements.
• Build a data‑driven value proposition linking clinical outcomes to revenue.
• Use meta‑analysis cost data and local LOS metrics for financial models.
• Secure leadership buy‑in by highlighting penalty avoidance and accreditation benefits.
• Monitor implementation continuously to sustain infection‑prevention gains over time.

Summary

The session led by veteran infection‑prevention consultants Connie Steed and Karen Hoffman focused on translating infection‑reduction efforts into concrete operational and financial metrics, especially length of stay (LOS) and revenue impact. They argued that infection control should be presented not merely as a safety function but as a driver of efficiency, cost avoidance, and profit.

Key insights included the use of meta‑analysis data from AHRQ to quantify the average treatment cost of hospital‑acquired infections, and the calculation of excess LOS using literature benchmarks combined with hospital occupancy and daily rates. By converting avoided infections into dollar values—over $2 million in treatment costs and more than $3 million in LOS savings for a 320‑bed community hospital—the presenters illustrated a compelling business case.

A highlighted example was Hospital A’s adoption of nasal decolonization in March 2022. The program eliminated central‑line‑associated bloodstream infections in ICUs, reduced surgical‑site infections and MRSA cases, and avoided 18 clabs, 37 SSIs, and nine MRSA lab IDs. This translated into the multi‑million‑dollar financial impact and ultimately zero penalties for the institution, underscoring the importance of sustained monitoring and leadership engagement.

The implication for health‑care leaders is clear: robust infection‑prevention programs can directly improve throughput, reduce penalties, enhance accreditation readiness, and protect institutional reputation. Developing data‑driven value propositions, aligning initiatives with organizational priorities, and continuously tracking outcomes are essential steps to secure resources and expand high‑impact interventions.

Original Description

In this webinar, hosted by Nozin, renowned speakers Connie Steed, MSN, RN, CIC, FAPIC and Karen Hoffmann, RN, MS, BSN, CIC, FAPIC, FSHEA discuss the benefits of concentrating your time on quality improvement strategies that have meaningful operational and financial impact.

Well-designed infection prevention (IP) programs reduce healthcare-associated infections which often result in decreased LOS and increased throughput and revenue. An IP strategy using nasal decolonization as a horizontal approach will be discussed demonstrating actual operational and financial benefits.